OrbiMed’s Longboard Pharmaceuticals LBPH Stock Holding History
Bought
Maintained
Sold
OrbiMed's LBPH Position: Q4 2024 in Review
OrbiMed sold out of Longboard Pharmaceuticals (LBPH) in Q4 2024, closing a stake of 170,000 shares — an estimated $5.67M sold.
OrbiMed first reported a position in LBPH in Q1 2021 and held it in 8 quarters. The position peaked at $5.67M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.
- OrbiMed reported no remaining Longboard Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
- OrbiMed sold 170,000 Longboard Pharmaceuticals shares in Q4 2024, an estimated $5.67M.
- OrbiMed first reported a position in Longboard Pharmaceuticals in Q1 2021 and held it in 8 quarters.
- OrbiMed's Longboard Pharmaceuticals position peaked at $5.67M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals as of Q4 2024.
Based on OrbiMed's 13F filing for Q4 2024, filed 14 Feb 2025.